Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward

Hum Vaccin Immunother. 2022 Dec 31;18(1):2034457. doi: 10.1080/21645515.2022.2034457. Epub 2022 Mar 3.

Abstract

Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in global healthcare. While more than half of the population of the developed countries have been fully vaccinated, only a small percentage of the African population has received one vaccine dose so far, a far cry from the global vaccination targets. Furthermore, several low and middle income (LMICs) African countries lack the competence, infrastructure, logistics, and financial resources to mass-vaccinate their populations. This paper highlights the causes and implications of the low COVID-19 vaccine coverage on Africa and the global community, and discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.

Keywords: Africa; COVID-19 pandemic; COVID-19 vaccination; Covid-19 vaccine inequity; LMIC; SARS-COV-2; developing countries; disparities; low coverage of vaccine; vaccine hesitancy.

MeSH terms

  • Africa / epidemiology
  • COVID-19 Vaccines*
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.